Dendritic cells: biology of the skin

Allergic contact dermatitis results from a T‐cell‐mediated, delayed‐type hypersensitivity immune response induced by allergens. Skin dendritic cells (DCs) play a central role in the initiation of allergic skin responses. Following encounter with an allergen, DCs become activated and undergo maturation and differentiate into immunostimulatory DCs and are able to present antigens effectively to T cells. The frequency of allergic skin disorders has increased in the past decades. Therefore, the identification of potential sensitizing chemicals is important for skin safety. Traditionally, predictive testing for allergenicity has been conducted in animal models. For regulatory reasons, animal use for sensitization testing of compounds for cosmetic purposes is shortly to be prohibited in Europe. Therefore, new non‐animal‐based test methods need to be developed. Several DC‐based assays have been described to discriminate allergens from irritants. Unfortunately, current in vitro methods are not sufficiently resilient to identify allergens and therefore need refinement. Here, we review the immunobiology of skin DCs (Langerhans’ cells and dermal dendritic cells) and their role in allergic and irritant contact dermatitis and then explore the possible use of DC‐based models for discriminating between allergens and irritants.

[1]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[2]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[3]  N. Sanjuán,et al.  Pattern of cytokine receptors expressed by human dendritic cells migrated‘qc from dermal explants , 1997, Immunology.

[4]  H S Rosenkranz,et al.  Development, characterization and application of predictive-toxicology models. , 1999, SAR and QSAR in environmental research.

[5]  Yuetsu Tanaka,et al.  Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals1 , 2002, The Journal of Immunology.

[6]  Thomas N. Sato,et al.  Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. , 2004, The Journal of clinical investigation.

[7]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[8]  S. Hudak,et al.  The CC Chemokine Receptor-7 Ligands 6Ckine and Macrophage Inflammatory Protein-3β Are Potent Chemoattractants for In Vitro- and In Vivo-Derived Dendritic Cells , 1999, The Journal of Immunology.

[9]  D. von Bubnoff,et al.  Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. , 2004, The Journal of investigative dermatology.

[10]  V. McFarland,et al.  Expression of E‐cadherin by murine dendritic cells: E‐cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells , 1994, European journal of immunology.

[11]  E. Kremmer,et al.  Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells , 1999, European journal of immunology.

[12]  H. Pinedo,et al.  A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor , 2006, Journal of leukocyte biology.

[13]  J. Wilcox,et al.  Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. , 1999, The Journal of investigative dermatology.

[14]  S. Gibbs,et al.  Increased CCL27–CCR10 expression in allergic contact dermatitis: implications for local skin memory , 2004, The Journal of pathology.

[15]  Camilla K. Smith,et al.  Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. , 2000, Toxicology and applied pharmacology.

[16]  P. Amrolia,et al.  Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. , 2003, Blood.

[17]  R. Baer,et al.  The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. , 1976, The Journal of investigative dermatology.

[18]  Z. Berneman,et al.  Cytokine transcript profiling in CD34+-progenitor derived dendritic cells exposed to contact allergens and irritants. , 2005, Toxicology letters.

[19]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[20]  Y. Kobayashi Langerhans’ cells produce type IV collagenase (MMP‐9) following epicutaneous stimulation with haptens , 1997, Immunology.

[21]  D. Harlan,et al.  Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model , 1999, The Journal of Immunology.

[22]  D. Heresbach,et al.  Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells. , 2005, Toxicology.

[23]  A. Iwasaki Mucosal dendritic cells. , 2007, Annual review of immunology.

[24]  M. Amagai,et al.  Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin , 1993, Nature.

[25]  F. Sallusto,et al.  Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. , 2000, Science.

[26]  Ian Kimber,et al.  The local lymph node assay: past, present and future , 2002, Contact dermatitis.

[27]  D. Weissman,et al.  Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro , 2002, Journal of leukocyte biology.

[28]  H. Mitsui,et al.  Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. , 2004, The Journal of allergy and clinical immunology.

[29]  S. Dower,et al.  IL-1Rrp Is a Novel Receptor-like Molecule Similar to the Type I Interleukin-1 Receptor and Its Homologues T1/ST2 and IL-1R AcP (*) , 1996, The Journal of Biological Chemistry.

[30]  M. Birbeck,et al.  An Electron Microscope Study of Basal Melanocytes and High-Level Clear Cells (Langerhans Cells) in Vitiligo * , 1961 .

[31]  D. Schmitt,et al.  Novel Protein Kinase C and Matrix Metalloproteinase Inhibitors of Vegetable Origin as Potential Modulators of Langerhans Cell Migration following Hapten-Induced Sensitization , 2004, International Archives of Allergy and Immunology.

[32]  I TOEROE,et al.  [ON THE LYMPH NODES]. , 1964, Verhandlungen der Anatomischen Gesellschaft.

[33]  V. Verhasselt,et al.  Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. , 1997, Journal of immunology.

[34]  A. Blauvelt,et al.  Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection , 1997, Nature Medicine.

[35]  C. Dong,et al.  B7S1, a novel B7 family member that negatively regulates T cell activation. , 2003, Immunity.

[36]  S. Aiba,et al.  Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co‐stimulatory molecules , 1997, European journal of immunology.

[37]  A. Blauvelt,et al.  Human Langerhans cells express E-cadherin. , 1995, The Journal of investigative dermatology.

[38]  J. Villadangos,et al.  MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. , 2001, Immunity.

[39]  K M Ardeshna,et al.  The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. , 2000, Blood.

[40]  C. Thompson,et al.  Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. , 1993, Journal of immunology.

[41]  B. Malissen,et al.  Langerhans cells--revisiting the paradigm using genetically engineered mice. , 2006, Trends in immunology.

[42]  M. Noris,et al.  Natural versus adaptive regulatory T cells. , 2005, Contributions to nephrology.

[43]  G. Schuler,et al.  Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.

[44]  M. Kapsenberg Tweaking of memory T helper 2 cells by TSLP. , 2006, Immunity.

[45]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[46]  W. Pichler Direct T-cell stimulations by drugs--bypassing the innate immune system. , 2005, Toxicology.

[47]  R. Steinman,et al.  The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells , 2000, The Journal of experimental medicine.

[48]  S. Narumiya,et al.  Prostaglandin E2–EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells , 2003, Nature Medicine.

[49]  C. Albanesi,et al.  Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis. , 2002, The Journal of investigative dermatology.

[50]  E. Perrier,et al.  Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2‐mediated inflammatory conditions respond differently to proinflammatory stimuli , 2006, Journal of leukocyte biology.

[51]  Richard A Flavell,et al.  Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells , 2004, Cell.

[52]  E. Buehler,et al.  DELAYED CONTACT HYPERSENSITIVITY IN THE GUINEA PIG. , 1965, Archives of dermatology.

[53]  S. Gibbs,et al.  Nickel‐responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10 , 2004, The British journal of dermatology.

[54]  A. Lanzavecchia,et al.  Serial triggering of many T-cell receptors by a few peptide–MHC complexes , 1995, Nature.

[55]  J. Banchereau,et al.  The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface , 1999, European journal of immunology.

[56]  J. van Bergen,et al.  A New Type of Metal Recognition by Human T Cells , 2003, The Journal of experimental medicine.

[57]  A. Régnault,et al.  TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. , 1999, Journal of immunology.

[58]  A. Enk,et al.  Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.

[59]  R. Lavker,et al.  Determinants of immune cell trafficking in the skin. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[60]  I. Kimber,et al.  Systemic migration of dendritic cells during contact sensitization. , 1990, Immunology.

[61]  Simon C Watkins,et al.  Dermal-resident CD14+ cells differentiate into Langerhans cells , 2001, Nature Immunology.

[62]  G. Patlewicz,et al.  Skin‐sensitization structure‐activity relationships for aldehydes , 2001, Contact dermatitis.

[63]  T. Ito,et al.  A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. , 1999, Journal of immunology.

[64]  A. Sher,et al.  Single Cell Analysis Reveals That IL-4 Receptor/Stat6 Signaling Is Not Required for the In Vivo or In Vitro Development of CD4+ Lymphocytes with a Th2 Cytokine Profile , 2000, The Journal of Immunology.

[65]  S. Gibbs,et al.  CXCL8 secretion by dendritic cells predicts contact allergens from irritants. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[66]  C. Baena-Cagnani,et al.  Secondary Lymphoid Tissue Chemokine (CCL21) Is Upregulated in Allergic Contact Dermatitis , 2004, International Archives of Allergy and Immunology.

[67]  F. Sallusto,et al.  The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. , 2001, Current opinion in immunology.

[68]  E. Padovan,et al.  T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. , 1996, Toxicology.

[69]  B. Gilchrest,et al.  Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin‐10 in human keratinocytes , 2003, Experimental dermatology.

[70]  W. Sterry,et al.  Common pathogenetic pathways in allergic and irritant contact dermatitis. , 1992, The Journal of investigative dermatology.

[71]  S. Ho,et al.  Human thymic stromal lymphopoietin promotes dendritic cell–mediated CD4+ T cell homeostatic expansion , 2004, Nature Immunology.

[72]  Friedrich Herberg,et al.  Metal-Protein Complex-Mediated Transport and Delivery of Ni2+ to TCR/MHC Contact Sites in Nickel-Specific Human T Cell Activation1 , 2004, The Journal of Immunology.

[73]  V. Kindler,et al.  A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers , 2001, The Journal of Immunology.

[74]  M. Furue,et al.  Expression of cutaneous lymphocyte-associated antigen defined by monoclonal antibody HECA-452 on human Langerhans cells. , 1996, Journal of dermatological science.

[75]  G. Schlewer,et al.  Allergic contact dermatitis to alpha-methylene-gamma-butyrolactones. Preparation of alantolactone-protein conjugates and induction of contact sensitivity in the guinea pig by an alantolactone-skin protein conjugate. , 1980, Molecular immunology.

[76]  M. Mommaas,et al.  Macrophages, but not Langerhans cell-like cells of dendritic lineage, express the CD36 molecule in normal human dermis: relevance to downregulatory cutaneous immune responses? , 1996, The Journal of investigative dermatology.

[77]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[78]  S. Spiekstra,et al.  Induction of cytokine (interleukin‐1α and tumor necrosis factor‐α) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure , 2005, Experimental dermatology.

[79]  J. Flier,et al.  The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. , 1999, The Journal of investigative dermatology.

[80]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[81]  E. Bröcker,et al.  Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. , 1995, Journal of immunology.

[82]  T. Mosmann,et al.  Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. , 1994, Journal of immunology.

[83]  I. Kimber,et al.  A murine local lymph node assay for the identification of contact allergens , 2004, Archives of Toxicology.

[84]  M. Udey,et al.  Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. , 1996, The Journal of investigative dermatology.

[85]  Lisa M. Ebert,et al.  Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. , 2005, Immunity.

[86]  I Kimber,et al.  Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[87]  J. Flier,et al.  Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation , 2001, The Journal of pathology.

[88]  Jeffrey A. Bluestone,et al.  Opinion-regulatory lymphocytes: Natural versus adaptive regulatory T cells , 2003, Nature Reviews Immunology.

[89]  Grace Patlewicz,et al.  Skin sensitization: reaction mechanistic applicability domains for structure-activity relationships. , 2005, Chemical research in toxicology.

[90]  H. Smits,et al.  Dendritic cell-mediated T cell polarization , 2004, Springer Seminars in Immunopathology.

[91]  S. Aiba,et al.  Phenotypic and functional characteristics of in vivo-activated Langerhans cells. , 1990, Journal of immunology.

[92]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[93]  C. J. Barnes,et al.  Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. , 2006, Immunity.

[94]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[95]  F. Geissmann,et al.  Transforming Growth Factor (cid:98) 1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells , 2022 .

[96]  Michael Sixt,et al.  The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. , 2005, Immunity.

[97]  Y. Liu,et al.  The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. , 1999, Journal of immunology.

[98]  H Tuschl,et al.  Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[99]  A. Foussat,et al.  A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation 1 , 2003, The Journal of Immunology.

[100]  P. Kalinski,et al.  Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarized phenotype in dendritic cells: role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18. , 2003, The Journal of investigative dermatology.

[101]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[102]  H. Sakaguchi,et al.  Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[103]  I. Kimber,et al.  Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration , 1997, Immunology.

[104]  G. Wood,et al.  Human Langerhans cells express a novel form of the leukocyte common antigen (CD45). , 1998, The Journal of investigative dermatology.

[105]  F. Nestle,et al.  Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. , 2001, The Journal of investigative dermatology.

[106]  T. Bieber,et al.  Tumor necrosis factor-alpha- and IL-4-independent development of Langerhans cell-like dendritic cells from M-CSF-conditioned precursors. , 2006, The Journal of investigative dermatology.

[107]  D. Jäger,et al.  The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes , 2000, Cell.

[108]  J. Banchereau,et al.  Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells , 2001, The Journal of experimental medicine.

[109]  W. Kamps,et al.  Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. , 1995, The American journal of pathology.

[110]  K. Nishioka,et al.  IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression. , 1999, The Journal of investigative dermatology.

[111]  T. Vogl,et al.  Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate. , 1999, The Journal of investigative dermatology.

[112]  D. Jäger,et al.  In vitro model for contact sensitization: II. Induction of IL-1beta mRNA in human blood-derived dendritic cells by contact sensitizers. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[113]  Ian Kimber,et al.  Impact of Cutaneous IL-10 on Resident Epidermal Langerhans’ Cells and the Development of Polarized Immune Responses , 2005, The Journal of Immunology.

[114]  Asim Khwaja,et al.  The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte–derived dendritic cells , 2000 .

[115]  J. Davoust,et al.  Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. , 2000, Immunity.

[116]  Y. Aragane,et al.  In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. , 1994, The Journal of investigative dermatology.

[117]  J. Hartmann,et al.  The fine structure of the melanocyte and melanin granule. , 1961, The Journal of investigative dermatology.

[118]  A. Nusrat,et al.  Junctional Adhesion Molecule 1 Regulates Epithelial Cell Morphology through Effects on β1 Integrins and Rap1 Activity* , 2005, Journal of Biological Chemistry.

[119]  E. Hoefsmit,et al.  Migratory properties and functional capacities of human skin dendritic cells , 1995, The British journal of dermatology.

[120]  G Frank Gerberick,et al.  Identification of gene expression changes induced by chemical allergens in dendritic cells: opportunities for skin sensitization testing. , 2006, The Journal of investigative dermatology.

[121]  C. Griffiths,et al.  Cytokines and Langerhans cell mobilisation in mouse and man. , 2005, Cytokine.

[122]  I. Kimber,et al.  Interleukin (IL)‐18 induces Langerhans cell migration by a tumour necrosis factor‐α‐ and IL‐1β‐dependent mechanism , 2001, Immunology.

[123]  T. Rustemeyer,et al.  Analysis of effector and regulatory immune reactivity to nickel , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[124]  M. Gayle,et al.  T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*) , 1996, The Journal of Biological Chemistry.

[125]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[126]  M. Moser,et al.  Effect of interleukin‐10 on dendritic cell maturation and function , 1997, European journal of immunology.

[127]  I. Fabre,et al.  The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. , 2006, Toxicology and applied pharmacology.

[128]  H. Saeki,et al.  Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. , 1999, Journal of immunology.

[129]  S. Carroll,et al.  Exposure of human keratinocytes and fibroblasts in vitro to nickel sulphate ions induces synthesis of stress proteins Hsp72 and Hsp90. , 2000, Acta dermato-venereologica.

[130]  I. Kimber,et al.  Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function , 1999, Archives of Dermatological Research.

[131]  M. Furue,et al.  Epitope mapping of CD1a, CD1b, and CD1c antigens in human skin: differential localization on Langerhans cells, keratinocytes, and basement membrane zone. , 1992, The Journal of investigative dermatology.

[132]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[133]  D. Strunk,et al.  Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. , 1996, Blood.

[134]  Antonio Lanzavecchia,et al.  Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.

[135]  N. Romani,et al.  Expression of C-type lectin receptors by subsets of dendritic cells in human skin. , 2004, International immunology.

[136]  G. Thorbecke,et al.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. , 1976, Cellular immunology.

[137]  J. Wilkinson,et al.  Reduced frequency of nickel allergy upon oral nickel contact at an early age , 1991, Clinical and experimental immunology.

[138]  R. Förster,et al.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.

[139]  P. Allavena,et al.  Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. , 2005, Blood.

[140]  R. Karr,et al.  Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone , 1996, The Journal of experimental medicine.

[141]  P. Kalinski,et al.  Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. , 1999, Journal of immunology.

[142]  P. Allavena,et al.  IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. , 1995, European cytokine network.

[143]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[144]  W. Fridman,et al.  IL-10 Induces CCR6 Expression During Langerhans Cell Development While IL-4 and IFN-γ Suppress It , 2001, The Journal of Immunology.

[145]  T. Geijtenbeek,et al.  A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions , 2002, Immunological reviews.

[146]  Jason G. Cyster,et al.  Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs , 1999, The Journal of experimental medicine.

[147]  P. Langerhans Ueber die Nerven der menschlichen Haut , 1868, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[148]  D. Liberato,et al.  Regiospecific attack of nitrogen and sulfur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein conjugate formation. , 1981, Journal of medicinal chemistry.

[149]  K. Wolff,et al.  Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period. , 1989, Journal of Immunology.

[150]  D. Fivenson,et al.  Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis , 1995, Journal of cutaneous pathology.

[151]  Stefan F. Martin,et al.  A high frequency of allergen‐specific 
CD8+ Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl , 2003, Experimental dermatology.

[152]  P. Das,et al.  Novel predictive assay for contact allergens using human skin explant cultures. , 1996, The American journal of pathology.

[153]  C. Albanesi,et al.  Effector and regulatory T cells in allergic contact dermatitis. , 2001, Trends in immunology.

[154]  P K Das,et al.  Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates , 2003, Experimental dermatology.

[155]  C. Willis,et al.  Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis , 1986, The British journal of dermatology.

[156]  C. Albanesi,et al.  Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. , 2000, The Journal of investigative dermatology.

[157]  C. Fenoglio,et al.  Reactivity of Langerhans cells with hybridoma antibody. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[158]  J. Hutchcroft,et al.  CD28/CTLA-4 and CD80/CD86 families , 1999, Immunologic research.

[159]  E. Shevach,et al.  The role of suppressor T cells in regulation of immune responses. , 2002, The Journal of allergy and clinical immunology.

[160]  R. Philip,et al.  IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy. , 1999, Journal of immunotherapy.

[161]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[162]  M. Matsumoto,et al.  Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. , 1999, Journal of immunology.

[163]  T. D. de Gruijl,et al.  MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. , 2002, Blood.

[164]  R. Clark,et al.  Response to Comment on “The Vast Majority of CLA+ T Cells Are Resident in Normal Skin” , 2006, The Journal of Immunology.

[165]  C. Caux,et al.  Respective involvement of TGF‐β and IL‐4 in the development of Langerhans cells and non‐Langerhans dendritic cells from CD34+ progenitors , 1999, Journal of leukocyte biology.

[166]  E. Valk,et al.  Activation and translocation of p38 mitogen-activated protein kinase after stimulation of monocytes with contact sensitizers. , 2002, The Journal of investigative dermatology.

[167]  Z. Berneman,et al.  Gene expression signatures in CD34+-progenitor-derived dendritic cells exposed to the chemical contact allergen nickel sulfate. , 2006, Toxicology and applied pharmacology.

[168]  F. Koning,et al.  Distribution of HLA class II molecules in epidermal Langerhans cells in situ , 1995, European journal of immunology.

[169]  E. Bröcker,et al.  Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. , 2001, The American journal of pathology.

[170]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[171]  A. Enk,et al.  An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. , 1993, Journal of immunology.

[172]  S. Aiba,et al.  Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[173]  P. Perrin,et al.  Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.

[174]  G. de Panfilis,et al.  Adhesion molecules on the plasma membrane of epidermal cells. II. The intercellular adhesion molecule-1 is constitutively present on the cell surface of human resting Langerhans cells. , 1990, The Journal of investigative dermatology.

[175]  E. Valk,et al.  Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells. , 2003, The Journal of investigative dermatology.

[176]  R. Steinman,et al.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[177]  R. Clark,et al.  The Vast Majority of CLA+ T Cells Are Resident in Normal Skin1 , 2006, The Journal of Immunology.

[178]  G. M. Ridder,et al.  Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype , 2001, Archives of Dermatological Research.

[179]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[180]  T. Lloyd,et al.  Regulation of CD28 costimulation in human CD8+ T cells. , 1997, Journal of immunology.